Investors & Media

Corporate Profile

Abeona Therapeutics is focused on developing and delivering gene therapy products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases such as Sanfilippo syndrome, Epidermolysis Bullosa, Batten disease, Fanconi anemia and other rare disorders.

Events & Presentations

Bloomberg Biotech Innovations Conference
Monday, April 9, 2018 in New York, NY
Abeona Presentation: 2:30pm ET
Event will be streamed live on the Bloomberg terminal
Link: http://b.bloomberg.com/reg-BiotechInnovations?src=SA

Abeona Fourth Quarter 2017 Earnings Call
Tuesday, March 27th at 10:00 am ET
877-407-9210 (toll free domestic)
201-689-8049 (International)

Barclays Global Healthcare Conference 2018
March 13-15, 2018 in Miami, FL
Webcast: https://cc.talkpoint.com/barc002/031318a_as/?entity=74_PGV3TNM

RBC Capital Markets 2018 Global Healthcare Conference
https://www.rbccm.com/en/about-us/conferences.page
February 21-22, 2018 in New York City, NY

14th Annual WORLDSymposium – Lysosomal Diseases
https://www.worldsymposia.org
February 5 – 9, 2018 in San Diego, CA
Webcast: https://www.veracast.com/webcasts/rbc/healthcare2018/81203233788.cfm

Investor & Media Contact

Christine Silverstein
Senior Vice President
Investor Relations & Finance

+1 (646) 813-4707
csilverstein@abeonatherapeutics.com

IR Documents

IR Links & Resources